Geak Poh Tan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Geak Poh Tan has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
- Barnaby Edward Young
National Centre for Infectious Diseases, Singapore, Singapore
2 shared publications - Sanjay Haresh Chotirmall
Lee Kong Chian School of Medicine Nanyang Technological University Singapore Singapore
2 shared publications - Ser Hon Puah
Department of Respiratory and Critical Care Medicine, Tan Tock Seng Hospital, Singapore
2 shared publications Adrian Kok Heng Tan
Home Ventilation and Respiratory Support Service, Intensive Care and Pain Medicine, Tan Tock Seng Hospital, Singapore, Singapore
1 shared publication- Adrienne Edwards
22Respiratory Department, Christchurch Hospital, Christchurch, Canterbury, New Zealand
1 shared publication Ai Ching Kor
Department of Respiratory and Critical Care Medicine, Intensive Care and Pain Medicine, Tan Tock Seng Hospital, Singapore, Singapore
1 shared publication
Latest Publications
- Open Access
- 25 August 2025
- Published by Academy of Medicine, Singapore in Annals of the Academy of Medicine, Singapore
- Vol. 54 (8) , 498-504
Advancing breast cancer and lung cancer screening: Expert perspectives to advance programmes in Singapore
Introduction: The high prevalence and mortality rates of breast cancer and lung cancer in Singapore necessitate robust screening programmes to enable early detection and intervention for improved patient outcomes, yet current uptake and coverage remain suboptimal. This narrative review synthesises expert perspectives from a 2024 roundtable discussion and proposes strategies to advance breast cancer and lung cancer screening programmes. Method: A 2024 roundtable convened clinical practitioners, health policymakers, researchers and patient advocates discussed current challenges and opportunities for improving cancer screening in Singapore. Perspectives and insights were analysed to identify themes related to existing programme gaps, opportunities for innovation and implementation challenges. Discussion: Singapore’s national breast cancer screening programme has been in place for over 2 decades, yet screening uptake remains suboptimal. A national lung cancer screening programme, in contrast, is still in its early stages of implementation. Regardless, employment of risk stratification approaches that integrate genetic, demographic and lifestyle factors could enhance screening effectiveness by identifying high-risk individuals, while also taking Singapore’s epidemiological trends into consideration. Integration of digital health technologies, artificial intelligence and behavioural change models can enhance cancer screening uptake and accuracy to overcome barriers such as low awareness, cultural beliefs and socioeconomic factors that contribute to low participation rates. Conclusion: Key recommendations include enhancing public awareness, refining screening guidelines, expanding access and applying innovative technologies. A coordinated effort among stakeholders is crucial to continually assess and enhance screening programmes to narrow the practice-policy gap and ultimately reduce breast cancer and lung cancer burden in Singapore.
- 25 August 2025
- Published by Academy of Medicine, Singapore in Annals of the Academy of Medicine, Singapore
- Vol. 54 (8) , 498-504
Open AccessAdvancing breast cancer and lung cancer screening: Expert perspectives to advance programmes in Singapore
Introduction: The high prevalence and mortality rates of breast cancer and lung cancer in Singapore necessitate robust screening programmes to enable early detection and intervention for improved patient outcomes, yet current uptake and coverage remain suboptimal. This narrative review synthesises expert perspectives from a 2024 roundtable discussion and proposes strategies to advance breast cancer and lung cancer screening programmes. Method: A 2024 roundtable convened clinical practitioners, health policymakers, researchers and patient advocates discussed current challenges and opportunities for improving cancer screening in Singapore. Perspectives and insights were analysed to identify themes related to existing programme gaps, opportunities for innovation and implementation challenges. Discussion: Singapore’s national breast cancer screening programme has been in place for over 2 decades, yet screening uptake remains suboptimal. A national lung cancer screening programme, in contrast, is still in its early stages of implementation. Regardless, employment of risk stratification approaches that integrate genetic, demographic and lifestyle factors could enhance screening effectiveness by identifying high-risk individuals, while also taking Singapore’s epidemiological trends into consideration. Integration of digital health technologies, artificial intelligence and behavioural change models can enhance cancer screening uptake and accuracy to overcome barriers such as low awareness, cultural beliefs and socioeconomic factors that contribute to low participation rates. Conclusion: Key recommendations include enhancing public awareness, refining screening guidelines, expanding access and applying innovative technologies. A coordinated effort among stakeholders is crucial to continually assess and enhance screening programmes to narrow the practice-policy gap and ultimately reduce breast cancer and lung cancer burden in Singapore.
- Open Access
Implications of the 2022 lung function update and GLI global reference equations among patients with interstitial lung disease
Background Lung function testing remains a cornerstone in the assessment and management of interstitial lung disease (ILD) patients. The clinical implications of the Global Lung function Initiative (GLI) reference equations and the updated interpretation strategies remain uncertain. Methods Adult patients with ILD with baseline forced vital capacity (FVC) were included from the Australasian ILD registry and the National Healthcare Group ILD registry, Singapore. The European Coal and Steel Community and Miller reference equations were compared with the GLI reference equations to assess (a) differences in lung function percent predicted values; (b) ILD risk prediction models and (c) eligibility for ILD clinical trial enrolment. Results Among 2219 patients with ILD, 1712 (77.2%) were white individuals. Idiopathic pulmonary fibrosis (IPF), connective tissue disease-associated ILD and unclassifiable ILD predominated. Median FVC was 2.60 (2.01–3.36) L, forced expiratory volume in 1 s was 2.09 (1.67–2.66) L and diffusing capacity of the lungs for carbon monoxide (DLCO) was 13.60 (10.16–17.60) mL/min/mm Hg. When applying the GLI reference equations, the mean FVC percentage predicted was 8.8% lower (87.7% vs 78.9%, pConclusion Applying the GLI reference equations in patients with ILD leads to higher DLCO percentage predicted values and smaller lung volume percentage predicted values. While applying the GLI reference equations did not impact on prognostication, fewer patients met the clinical trial criteria for antifibrotic agents.
Open AccessImplications of the 2022 lung function update and GLI global reference equations among patients with interstitial lung disease
Background Lung function testing remains a cornerstone in the assessment and management of interstitial lung disease (ILD) patients. The clinical implications of the Global Lung function Initiative (GLI) reference equations and the updated interpretation strategies remain uncertain. Methods Adult patients with ILD with baseline forced vital capacity (FVC) were included from the Australasian ILD registry and the National Healthcare Group ILD registry, Singapore. The European Coal and Steel Community and Miller reference equations were compared with the GLI reference equations to assess (a) differences in lung function percent predicted values; (b) ILD risk prediction models and (c) eligibility for ILD clinical trial enrolment. Results Among 2219 patients with ILD, 1712 (77.2%) were white individuals. Idiopathic pulmonary fibrosis (IPF), connective tissue disease-associated ILD and unclassifiable ILD predominated. Median FVC was 2.60 (2.01–3.36) L, forced expiratory volume in 1 s was 2.09 (1.67–2.66) L and diffusing capacity of the lungs for carbon monoxide (DLCO) was 13.60 (10.16–17.60) mL/min/mm Hg. When applying the GLI reference equations, the mean FVC percentage predicted was 8.8% lower (87.7% vs 78.9%, pConclusion Applying the GLI reference equations in patients with ILD leads to higher DLCO percentage predicted values and smaller lung volume percentage predicted values. While applying the GLI reference equations did not impact on prognostication, fewer patients met the clinical trial criteria for antifibrotic agents.
- Open Access
- 1 December 2022
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 60 (6) , 2102962
Reference equations for evaluation of spirometry function tests in South Asia, and among South Asians living in other countries
Background: There are few data to support accurate interpretation of spirometry data in South Asia, a major global region with a high reported burden of chronic respiratory disease.Method: We measured lung function in 7453 healthy men and women aged ≥18 years, from Bangladesh, North India, South India, Pakistan and Sri Lanka, as part of the South Asia Biobank study. First, we assessed the accuracy of existing equations for predicting normal forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1) and FEV1/FVC ratio. Then, we used our data to derive (n=5589) and internally validate (n=1864) new prediction equations among South Asians, with further external validation among 339 healthy South Asians living in Singapore.Results: The Global Lung Initiative (GLI) and National Health and Nutrition Examination Survey consistently overestimated expiratory volumes (best fit GLI-African American, mean±sdz-score: FEV1−0.94±1.05, FVC −0.91±1.10; n=7453). Age, height and weight were strong predictors of lung function in our participants (p10.03±0.99, FVC 0.04±0.97, FEV1/FVC −0.03±0.99) and external validation (z-scores: FEV10.31±0.99, FVC 0.24±0.97, FEV1/FVC 0.16±0.91). Further adjustment for study regions improves the model fit, with highest accuracy for estimation of region-specific lung function in South Asia.Conclusion: We present improved equations for predicting lung function in South Asians. These offer the opportunity to enhance diagnosis and management of acute and chronic lung diseases in this major global population.
- 1 December 2022
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 60 (6) , 2102962
Open AccessReference equations for evaluation of spirometry function tests in South Asia, and among South Asians living in other countries
Background: There are few data to support accurate interpretation of spirometry data in South Asia, a major global region with a high reported burden of chronic respiratory disease.Method: We measured lung function in 7453 healthy men and women aged ≥18 years, from Bangladesh, North India, South India, Pakistan and Sri Lanka, as part of the South Asia Biobank study. First, we assessed the accuracy of existing equations for predicting normal forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1) and FEV1/FVC ratio. Then, we used our data to derive (n=5589) and internally validate (n=1864) new prediction equations among South Asians, with further external validation among 339 healthy South Asians living in Singapore.Results: The Global Lung Initiative (GLI) and National Health and Nutrition Examination Survey consistently overestimated expiratory volumes (best fit GLI-African American, mean±sdz-score: FEV1−0.94±1.05, FVC −0.91±1.10; n=7453). Age, height and weight were strong predictors of lung function in our participants (p10.03±0.99, FVC 0.04±0.97, FEV1/FVC −0.03±0.99) and external validation (z-scores: FEV10.31±0.99, FVC 0.24±0.97, FEV1/FVC 0.16±0.91). Further adjustment for study regions improves the model fit, with highest accuracy for estimation of region-specific lung function in South Asia.Conclusion: We present improved equations for predicting lung function in South Asians. These offer the opportunity to enhance diagnosis and management of acute and chronic lung diseases in this major global population.
- Open Access
- 29 June 2021
- Published by Wiley in Respirology Case Reports
- Vol. 9 (8) , e00807
Exercise intolerance due to chronotropic incompetence uncovered by cardiopulmonary exercise test: an often overlooked manifestation of ischaemic heart disease
A 60‐year‐old delivery man was referred for evaluation of unexplained exertional dyspnoea despite initial non‐diagnostic investigations, including pulmonary function tests and dobutamine stress echocardiography. A symptom‐limited cardiopulmonary exercise test (CPET) revealed chronotropic incompetence (CI), reduced oxygen uptake (VO2)/work slope at moderate–high workload, and ST‐segment depression on recovery electrocardiogram. Coronary angiogram confirmed severe stenosis in right coronary artery and left anterior descending artery, for which he underwent percutaneous coronary stenting and cardiac rehabilitation. An interval CPET showed improvement in heart rate (HR) response and aerobic capacity. CI is characterized by an attenuated HR response to incremental exercise or an increased HR reserve despite maximal effort. Clinically, it is an independent predictor of adverse cardiovascular events and mortality. CI is frequently overlooked, highlighting the importance of CPET in the diagnostic workup of unexplained dyspnoea.
- 29 June 2021
- Published by Wiley in Respirology Case Reports
- Vol. 9 (8) , e00807
Open AccessExercise intolerance due to chronotropic incompetence uncovered by cardiopulmonary exercise test: an often overlooked manifestation of ischaemic heart disease
A 60‐year‐old delivery man was referred for evaluation of unexplained exertional dyspnoea despite initial non‐diagnostic investigations, including pulmonary function tests and dobutamine stress echocardiography. A symptom‐limited cardiopulmonary exercise test (CPET) revealed chronotropic incompetence (CI), reduced oxygen uptake (VO2)/work slope at moderate–high workload, and ST‐segment depression on recovery electrocardiogram. Coronary angiogram confirmed severe stenosis in right coronary artery and left anterior descending artery, for which he underwent percutaneous coronary stenting and cardiac rehabilitation. An interval CPET showed improvement in heart rate (HR) response and aerobic capacity. CI is characterized by an attenuated HR response to incremental exercise or an increased HR reserve despite maximal effort. Clinically, it is an independent predictor of adverse cardiovascular events and mortality. CI is frequently overlooked, highlighting the importance of CPET in the diagnostic workup of unexplained dyspnoea.
- Open Access
- 1 December 2020
- Published by Elsevier in Physiotherapy
- Vol. 109, 1-3
Clinical course and physiotherapy intervention in 9 patients with COVID-19
- 1 December 2020
- Published by Elsevier in Physiotherapy
- Vol. 109, 1-3
Open AccessClinical course and physiotherapy intervention in 9 patients with COVID-19
- 1 November 2020
- Published by Elsevier in Respiratory Physiology & Neurobiology
- Vol. 282, 103515
Reversible platypnea-orthodeoxia in COVID-19 acute respiratory distress syndrome survivors
- 1 November 2020
- Published by Elsevier in Respiratory Physiology & Neurobiology
- Vol. 282, 103515
Reversible platypnea-orthodeoxia in COVID-19 acute respiratory distress syndrome survivors
- 1 March 2019
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 11 (3) , 795-804
The pattern of use and survival outcomes of a dedicated adult Home Ventilation and Respiratory Support Service in Singapore: a 7-year retrospective observational cohort study
Background: In Singapore, a dedicated adult multidisciplinary Home Ventilation and Respiratory Support Service (HVRSS) was set-up to assist individuals with chronic ventilatory failure. We aimed to study the use, survival outcomes and identify factors influencing survival in our cohort of ventilator-assisted individuals (VAIs). Methods: We retrospectively reviewed all referrals to HVRSS from 2009 to 2015. All VAIs were included and divided into 4 categories: (I) amyotrophic lateral sclerosis (ALS); (II) other neuromuscular and chest wall disease (NMCW); (III) spinal cord injury (SCI); and (IV) complex intensive care unit (ICU) groups for comparison of baseline characteristics, co-morbidities, therapy details and survival outcomes. Cox proportional analysis was used to identify important factors influencing survival for ALS and non-ALS VAIs. Results: There were 112 VAIs; most were male (63%) and ethnic Chinese (83%). At baseline, median [interquartile range (IQR)] age was 61 [46–69] years, body mass index was 20.2 (17.1–23.8) kg/m2 and forced vital capacity was 38 [24–65] %predicted. The three most common diseases were ALS (43%), SCI (13%) and congenital muscular dystrophies (6%). Seventy-four (66%) VAIs received non-invasive ventilation (NIV). Median survival for ALS, Complex ICU, SCI and NMCW VAIs were 1.8, 2.6, 4.2 and 6.7 years respectively. In ALS, NIV conversion to invasive mechanical ventilation (IMV) was associated with longer survival [hazard ratio (HR) 0.24]. In non-ALS VAIs, older age (HR 1.40) and cardiovascular comorbidities (HR 2.61) were poor prognostic factors. Conclusions: The HVRSS managed a heterogenous group of VAIs in Singapore and survival is comparable to published cohorts. ALS had the worst survival whereas NMCW had the best survival with Complex ICU and SCI groups in between. Transition from NIV to IMV, age and cardiovascular disease were important prognostic factors.
- 1 March 2019
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 11 (3) , 795-804
The pattern of use and survival outcomes of a dedicated adult Home Ventilation and Respiratory Support Service in Singapore: a 7-year retrospective observational cohort study
Background: In Singapore, a dedicated adult multidisciplinary Home Ventilation and Respiratory Support Service (HVRSS) was set-up to assist individuals with chronic ventilatory failure. We aimed to study the use, survival outcomes and identify factors influencing survival in our cohort of ventilator-assisted individuals (VAIs). Methods: We retrospectively reviewed all referrals to HVRSS from 2009 to 2015. All VAIs were included and divided into 4 categories: (I) amyotrophic lateral sclerosis (ALS); (II) other neuromuscular and chest wall disease (NMCW); (III) spinal cord injury (SCI); and (IV) complex intensive care unit (ICU) groups for comparison of baseline characteristics, co-morbidities, therapy details and survival outcomes. Cox proportional analysis was used to identify important factors influencing survival for ALS and non-ALS VAIs. Results: There were 112 VAIs; most were male (63%) and ethnic Chinese (83%). At baseline, median [interquartile range (IQR)] age was 61 [46–69] years, body mass index was 20.2 (17.1–23.8) kg/m2 and forced vital capacity was 38 [24–65] %predicted. The three most common diseases were ALS (43%), SCI (13%) and congenital muscular dystrophies (6%). Seventy-four (66%) VAIs received non-invasive ventilation (NIV). Median survival for ALS, Complex ICU, SCI and NMCW VAIs were 1.8, 2.6, 4.2 and 6.7 years respectively. In ALS, NIV conversion to invasive mechanical ventilation (IMV) was associated with longer survival [hazard ratio (HR) 0.24]. In non-ALS VAIs, older age (HR 1.40) and cardiovascular comorbidities (HR 2.61) were poor prognostic factors. Conclusions: The HVRSS managed a heterogenous group of VAIs in Singapore and survival is comparable to published cohorts. ALS had the worst survival whereas NMCW had the best survival with Complex ICU and SCI groups in between. Transition from NIV to IMV, age and cardiovascular disease were important prognostic factors.
- Open Access
- 7 February 2018
- Published by SAGE Publications in Chronic Respiratory Disease
- Vol. 15 (4) , 356-364
Patterns of use, survival and prognostic factors in patients receiving home mechanical ventilation in Western Australia: A single centre historical cohort study
Home mechanical ventilation (HMV) is used in a wide range of disorders associated with chronic hypoventilation. We describe the patterns of use, survival and predictors of death in Western Australia. We identified 240 consecutive patients (60% male; mean age 58 years and body mass index 31 kg m−2) referred for HMV between 2005 and 2010. The patients were grouped into four categories: motor neurone disorders (MND; 39%), pulmonary disease (PULM; 25%, mainly chronic obstructive pulmonary disease), non-MND neuromuscular and chest wall disorders (NMCW; 21%) and the obesity hypoventilation syndrome (OHS; 15%). On average, the patients had moderate ventilatory impairment (forced vital capacity: 51%predicted), sleep apnoea (apnoea-hypopnea index: 25 events h−1), sleep-related hypoventilation (transcutaneous carbon dioxide rise of 20 mmHg) and daytime hypercarbia (PCO2: 54 mmHg). Median durations of survival from HMV initiation were 1.0, 4.2, 9.9 and >11.5 years for MND, PULM, NMCW and OHS, respectively. Independent predictors of death varied between primary indications for HMV; the predictors included (a) age in all groups except for MND (hazard ratios (HRs) 1.03–1.10); (b) cardiovascular disease (HR: 2.35, 95% confidence interval (CI): 1.08–5.10) in MND; (c) obesity (HR: 0.28, 95% CI: 0.13–0.62) and oxygen therapy (HR: 0.33, 95% CI: 0.14–0.79) in PULM; and (d) forced expiratory volume in 1 s (%predicted; HR: 0.93, 95% CI: 0.88–1.00) in OHS.
- 7 February 2018
- Published by SAGE Publications in Chronic Respiratory Disease
- Vol. 15 (4) , 356-364
Open AccessPatterns of use, survival and prognostic factors in patients receiving home mechanical ventilation in Western Australia: A single centre historical cohort study
Home mechanical ventilation (HMV) is used in a wide range of disorders associated with chronic hypoventilation. We describe the patterns of use, survival and predictors of death in Western Australia. We identified 240 consecutive patients (60% male; mean age 58 years and body mass index 31 kg m−2) referred for HMV between 2005 and 2010. The patients were grouped into four categories: motor neurone disorders (MND; 39%), pulmonary disease (PULM; 25%, mainly chronic obstructive pulmonary disease), non-MND neuromuscular and chest wall disorders (NMCW; 21%) and the obesity hypoventilation syndrome (OHS; 15%). On average, the patients had moderate ventilatory impairment (forced vital capacity: 51%predicted), sleep apnoea (apnoea-hypopnea index: 25 events h−1), sleep-related hypoventilation (transcutaneous carbon dioxide rise of 20 mmHg) and daytime hypercarbia (PCO2: 54 mmHg). Median durations of survival from HMV initiation were 1.0, 4.2, 9.9 and >11.5 years for MND, PULM, NMCW and OHS, respectively. Independent predictors of death varied between primary indications for HMV; the predictors included (a) age in all groups except for MND (hazard ratios (HRs) 1.03–1.10); (b) cardiovascular disease (HR: 2.35, 95% confidence interval (CI): 1.08–5.10) in MND; (c) obesity (HR: 0.28, 95% CI: 0.13–0.62) and oxygen therapy (HR: 0.33, 95% CI: 0.14–0.79) in PULM; and (d) forced expiratory volume in 1 s (%predicted; HR: 0.93, 95% CI: 0.88–1.00) in OHS.
- Open Access
- 7 February 2018
- Published by Wiley in Respirology Case Reports
- Vol. 6 (3) , e00303
Reversible platypnoea–orthodeoxia syndrome in post‐tuberculosis bronchial stenosis
Bronchial stenosis is known to complicate endobronchial tuberculosis despite medical therapy. It is often associated with dyspnoea. In severe cases, bronchial stenosis results in airflow obstruction, impaired secretion clearance, and can lead to respiratory failure. We present an unusual observation of platypnoea–orthodeoxia syndrome in a young woman with acute atelectasis due to post‐tuberculosis bronchial stricture. Imaging revealed complete middle and right lower lobe atelectasis with a partially aerated right upper lobe. In the sitting posture, there was positional worsening of dyspnoea associated with an increase in the alveolar‐arterial oxygen gradient and shunt fraction. The likely mechanism was due to gravitational difference in ventilation–perfusion matching. The platypnoea–orthodeoxia syndrome was reversible following balloon dilatation of the bronchial stenosis and expansion of the collapsed lung.
- 7 February 2018
- Published by Wiley in Respirology Case Reports
- Vol. 6 (3) , e00303
Open AccessReversible platypnoea–orthodeoxia syndrome in post‐tuberculosis bronchial stenosis
Bronchial stenosis is known to complicate endobronchial tuberculosis despite medical therapy. It is often associated with dyspnoea. In severe cases, bronchial stenosis results in airflow obstruction, impaired secretion clearance, and can lead to respiratory failure. We present an unusual observation of platypnoea–orthodeoxia syndrome in a young woman with acute atelectasis due to post‐tuberculosis bronchial stricture. Imaging revealed complete middle and right lower lobe atelectasis with a partially aerated right upper lobe. In the sitting posture, there was positional worsening of dyspnoea associated with an increase in the alveolar‐arterial oxygen gradient and shunt fraction. The likely mechanism was due to gravitational difference in ventilation–perfusion matching. The platypnoea–orthodeoxia syndrome was reversible following balloon dilatation of the bronchial stenosis and expansion of the collapsed lung.